ici 204,219 has been researched along with Hepatitis D in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donkers, JM | 1 |
| Zehnder, B | 1 |
| van Westen, GJP | 1 |
| Kwakkenbos, MJ | 1 |
| IJzerman, AP | 1 |
| Oude Elferink, RPJ | 1 |
| Beuers, U | 1 |
| Urban, S | 1 |
| van de Graaf, SFJ | 1 |
1 other study available for ici 204,219 and Hepatitis D
| Article | Year |
|---|---|
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; | 2017 |